| |
|
Female |
|
|
|
Male |
|
|
| |
30 days (x) |
60days (y) |
120days (z) |
|
30days (x) |
60days (y) |
120days (z) |
|
| SOD |
Med (Min-Max) |
Med (Min-Max) |
Med (Min-Max) |
p |
Med (Min-Max) |
Med (Min-Max) |
Med (Min-Max) |
p |
| Control (n=6) |
11,0(10,0-25,0) |
e22,5(18,0-57,0) |
15,5(12,4-41,0) |
0,095 |
16,5(3,0-23,0) |
42,5(3,0-54,0) |
20,9(3,1-59,6) |
0,076 |
| 1% (n=6) |
15,5(1,0-32,0) |
c,e19,0(1,0-34,0) |
19,2(7,5-36,3) |
0,787 |
10,0(3,0-19,0)y |
40,0(12,0-50,09x |
20,6(9,2-32,3) |
0,016* |
| 2,5% (n=6) |
17,5(7,0-28,0) |
b41,0(15,0-62,0) |
27,8(17,3-35,7) |
0,055 |
19,5(5,0-26,0)y,z |
45,5(24,0-57,0)x,z |
31,7(12,2-42,1)x,y |
0,005* |
| 5% (n=6) |
21,5(9,0-26,0) |
e34,5(4,0-55,0) |
20,3(14,8-41,9) |
0,580 |
12,5(7,0-24,0)y |
44,0(19,0-62,0)x,z |
26,3(10,3-33,8)y |
0,007* |
| 10% (n=6) |
14,0(9,0-23,0)y,x |
a,b,d47,5(40,0-67,0)x,z |
22,0(11,3-40,8)x,y |
0,002* |
16,5(12,0-27,0) |
41,0(8,0-45,0)z |
11,7(1,1-31,8)y |
0,039* |
| p |
0,678 |
0,028* |
0,609 |
|
0,225 |
0,716 |
0,200 |
|
|
SOD, in female genders of 60th day: control<%10; %1<%2,5; %1<%10 and %5<%10; SOD,in female genders of %10 group; 30th day<120th day<60th day. SOD, in %1 group of male genders;30th day<60th day; in male genders of %2,5 group; 30th day<120th day<60th day; in male genders of %5 group; 30th day<60th day and 120th day<60th day, in male genders of %10 group; 60th day>120th day. |
|
